Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0000950170-25-017032

Options or other derivatives

  • CFO & Head of Corp. Dev. acquired 157,820 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ridloff Elena CFO & Head of Corp. Dev. 2025-02-06 Grant or award · Stock Option (Right to Buy) +157,820 157,820 D
Loading xslF345X05/ownership.xml…